Question

Which myocardial infarction patient listed below would be a candidate for reteplase (Retavase) therapy?

1. 70-year-old male with active GI bleed
2. 45-year-old female with a 2-week-old cranial artery repair
3. 54-year-old female with type II diabetes
4. 62-year-old with a recent hemorrhagic stroke

Answer 1

Step-by-step explanation:

Le traitement par retéplase (Retavase) est généralement indiqué pour le traitement de l'infarctus du myocarde. Parmi les options fournies, le candidat le plus approprié pour ce traitement serait la femme de 62 ans présentant un accident vasculaire cérébral hémorragique récent (option 4). Cependant, il est essentiel de noter que chaque cas clinique est unique, et les décisions de traitement doivent être prises par des professionnels de la santé en fonction de l'évaluation complète du patient et de ses antécédents médicaux.

Answer 2

The suitable candidate for reteplase therapy among those listed is the 54-year-old female with type II diabetes, as she does not have contraindications such as a history of bleeding or recent surgery that would increase the risk of bleeding.

Step-by-step explanation:

The appropriate patient for reteplase (Retavase) therapy, which is a thrombolytic agent used to treat myocardial infarction (infarction), would be the one without contraindications for thrombolytic therapy. Of the patients listed:

• The 70-year-old male with an active GI bleed would not be a candidate due to the risk of exacerbating bleeding.
• The 45-year-old female with a 2-week-old cranial artery repair is also not suitable due to the potential for bleeding at the surgical site.
• The 62-year-old with a recent hemorrhagic stroke is contraindicated because of the high risk of bleeding in the brain.
• The 54-year-old female with type II diabetes does not have any of the listed contraindications and would be a suitable candidate for reteplase therapy.